Pierre Fabre at ASH 2026
Dec 12–15, 2026 New Orleans, LA ~30k attendees Website
Pierre Fabre brings 1 presentation to ASH 2026 in New Orleans, and exhibits at Booth 2847, 2851. Its research centres on access to treatment for a transplant complication. It covers shipping tabelecleucel internationally for EBV-positive post-transplant lymphoproliferative disease.
| Organization | ASH 2026 Attendance |
|---|---|
Pierre Fabre Castres, France | |
French pharmaceutical and dermo-cosmetics group; its US unit develops therapies, including a treatment for EBV-positive lymphoproliferative disease after transplant. | Booth Exhibiting at Booth 2847, 2851 Sat, Dec 1211:00am–5:00pmSun, Dec 1310:00am–5:00pmMon, Dec 1410:00am–2:00pm |
Find decision makers at Pierre Fabre
Tell us what you sell and we’ll find the people at Pierre Fabre most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the American Society of Hematology (ASH). Submit a correction